These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16142801)

  • 21. Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein.
    Meng Q; Wang W; Shi X; Jin Y; Zhang Y
    Clin Dev Immunol; 2011; 2011():831704. PubMed ID: 21765853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of immunization with a recombinant cholera toxin B subunit/somatostatin fusion protein on immune response and growth hormone levels in mice.
    Wu B; Yuan T; Qi R; He J; Fu Y; Niu D; Li W
    Biotechnol Lett; 2012 Dec; 34(12):2199-203. PubMed ID: 22932932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes.
    Bregenholt S; Wang M; Wolfe T; Hughes A; Baerentzen L; Dyrberg T; von Herrath MG; Petersen JS
    Scand J Immunol; 2003 May; 57(5):432-8. PubMed ID: 12753499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
    Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice.
    Arêas AP; Oliveira ML; Miyaji EN; Leite LC; Aires KA; Dias WO; Ho PL
    Biochem Biophys Res Commun; 2004 Aug; 321(1):192-6. PubMed ID: 15358234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
    Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
    Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice.
    Chang Y; Yap S; Ge X; Piganelli J; Bertera S; Giannokakis N; Mathews C; Prud'homme G; Trucco M
    Gene Ther; 2005 Dec; 12(23):1679-85. PubMed ID: 16107864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen.
    Marazuela EG; Rodríguez R; Fernández-García H; García MS; Villalba M; Batanero E
    Mol Immunol; 2008 Jan; 45(2):438-45. PubMed ID: 17662454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes.
    Dunsavage MB; O'Leary CJ; Baumgart TD; Solvason N; Howard M; Lafferty K; Deshpande S; Reich EP
    J Autoimmun; 1999 Jun; 12(4):233-42. PubMed ID: 10330294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes.
    Liu B; Yue Y; Yang Y; Jin Y
    PLoS One; 2016; 11(1):e0147260. PubMed ID: 26783749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice.
    Urbanek-Ruiz I; Ruiz PJ; Paragas V; Garren H; Steinman L; Fathman CG
    Clin Immunol; 2001 Aug; 100(2):164-71. PubMed ID: 11465945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo.
    Sadeghi H; Bregenholt S; Wegmann D; Petersen JS; Holmgren J; Lebens M
    Immunology; 2002 Jun; 106(2):237-45. PubMed ID: 12047753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine.
    Tarkowski A; Sun JB; Holmdahl R; Holmgren J; Czerkinsky C
    Arthritis Rheum; 1999 Aug; 42(8):1628-34. PubMed ID: 10446861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of intranasal vaccination against Angiostrongylus costaricensis using a serine/threonine phosphatase 2 A synthetic peptide and recombinant antigens.
    Solano-Parada J; Gonzalez-Gonzalez G; Torró LM; dos Santos MF; Espino AM; Burgos M; Osuna A
    Vaccine; 2010 Jul; 28(32):5185-96. PubMed ID: 20558243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.
    Odumosu O; Payne K; Baez I; Jutzy J; Wall N; Langridge W
    Immunobiology; 2011 Apr; 216(4):447-56. PubMed ID: 20956025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Construction of mucosal vaccine derived from HBV surface antigen epitope A and the assay of its immunogenicity].
    Liu X; Yang G; Qiu B; Tian P
    Wei Sheng Wu Xue Bao; 2001 Oct; 41(5):625-9. PubMed ID: 12552813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses.
    Bublin M; Hoflehner E; Wagner B; Radauer C; Wagner S; Hufnagl K; Allwardt D; Kundi M; Scheiner O; Wiedermann U; Breiteneder H
    Vaccine; 2007 Dec; 25(50):8395-404. PubMed ID: 17997199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.